What is William Blair's Forecast for PIII FY2024 Earnings?

P3 Health Partners Inc. (NASDAQ:PIII - Free Report) - Stock analysts at William Blair dropped their FY2024 EPS estimates for P3 Health Partners in a note issued to investors on Wednesday, November 13th. William Blair analyst R. Daniels now forecasts that the company will earn ($0.67) per share for the year, down from their prior estimate of ($0.23). The consensus estimate for P3 Health Partners' current full-year earnings is ($0.67) per share. William Blair also issued estimates for P3 Health Partners' Q4 2024 earnings at ($0.17) EPS, Q1 2025 earnings at ($0.11) EPS, Q2 2025 earnings at ($0.09) EPS, Q3 2025 earnings at ($0.11) EPS, Q4 2025 earnings at ($0.13) EPS and FY2025 earnings at ($0.42) EPS.

P3 Health Partners Stock Down 7.1 %

PIII traded down $0.02 during midday trading on Monday, reaching $0.21. The company's stock had a trading volume of 275,263 shares, compared to its average volume of 471,280. The firm has a market capitalization of $75.94 million, a price-to-earnings ratio of -0.27 and a beta of 1.15. The company has a current ratio of 0.53, a quick ratio of 0.69 and a debt-to-equity ratio of 1.11. P3 Health Partners has a 1 year low of $0.20 and a 1 year high of $1.78. The stock's 50-day moving average is $0.40 and its 200-day moving average is $0.51.

Insiders Place Their Bets

In other news, major shareholder Pacific Founders Ugp I. Chicago bought 80,000 shares of the company's stock in a transaction dated Friday, September 6th. The shares were purchased at an average price of $0.49 per share, for a total transaction of $39,200.00. Following the completion of the purchase, the insider now owns 76,785,438 shares in the company, valued at approximately $37,624,864.62. This represents a 0.10 % increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Over the last quarter, insiders have acquired 400,000 shares of company stock worth $205,600. 17.86% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Armistice Capital LLC purchased a new stake in P3 Health Partners during the second quarter valued at approximately $3,557,000. Renaissance Technologies LLC increased its stake in shares of P3 Health Partners by 188.1% in the second quarter. Renaissance Technologies LLC now owns 111,800 shares of the company's stock worth $50,000 after purchasing an additional 73,000 shares in the last quarter. Geode Capital Management LLC increased its stake in shares of P3 Health Partners by 115.2% in the third quarter. Geode Capital Management LLC now owns 1,029,259 shares of the company's stock worth $398,000 after purchasing an additional 550,925 shares in the last quarter. Emfo LLC grew its stake in P3 Health Partners by 39.8% during the second quarter. Emfo LLC now owns 1,427,689 shares of the company's stock valued at $643,000 after acquiring an additional 406,418 shares in the last quarter. Finally, Sanders Morris Harris LLC grew its stake in P3 Health Partners by 16.3% during the second quarter. Sanders Morris Harris LLC now owns 142,998 shares of the company's stock valued at $64,000 after acquiring an additional 20,000 shares in the last quarter. Institutional investors own 7.75% of the company's stock.

P3 Health Partners Company Profile

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.